Hepatocellular Carcinoma News and Research

RSS

Hepatocellular Carcinoma is a type of adenocarcinoma, the most common type of liver tumor.

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

5 Nov 2019

Deaths from liver cancer increased 3-fold over 20 years in England

Liver cancer is rapidly moving up the cancer killer ranks in England, according to a new study that is to be presented at the 201th NCRI Cancer Conference on November 2, 2019. Both the number of new cases and the mortality rate from hepatocellular carcinoma (HCC), have tripled, over the period from 1997 to 2016. HCC is the most common form of liver cancer. Moreover, a quarter of these cases occur among the least privileged fifth of society.

3 Nov 2019

Proton radiation therapy can help treat patients with hepatocellular carcinoma

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. One study (Sanford et al.) suggests that proton radiation, compared to traditional photon radiation, can extend overall survival with reduced toxicity.

30 Oct 2019

Studies support use of proton radiation therapy to treat patients with fatal type of liver cancer

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma, a common but often fatal type of liver cancer for which there are limited treatment options.

30 Oct 2019

MRI contrast agent enables early detection of liver disease

Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents.

30 Oct 2019

ACG 2019 to review latest scientific advances in diagnosis and treatment of digestive diseases

More than 5,500 gastroenterologists and other health care professionals will convene at the Henry B. Gonzalez Convention Center in San Antonio, TX for the premier clinical gastroenterology event - the American College of Gastroenterology's 84th Annual Scientific Meeting and Postgraduate Course (ACG 2019) - to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.

30 Oct 2019

IDIBELL researchers identify involvement of cell membrane protein in liver cancer

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have just described for the first time the crucial involvement of a cell membrane protein in the development and progression of liver cancer, according to an article published in the Journal of Hepatology.

29 Oct 2019

Study shows why fatty liver disease contributes to increase in liver cancer

Fatty liver disease is contributing to an increase in liver cancer and basic scientists at The University of Texas Health Science at Houston have new insight as to why.

16 Oct 2019

Spectrum Health, MSU researchers aim to find new or better treatments for "orphan diseases"

The National Institutes of Health has awarded a Michigan State University researcher a $2.1 million, five-year grant to search vast databases of existing drugs.

16 Oct 2019

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

An Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the "dark matter" of human cancer DNA.

9 Oct 2019

Scientists demonstrate potential method for treating advanced liver cancers

Liver cancer is the second leading cause of cancer-related deaths worldwide. The most common primary liver cancer in adults is known as hepatocellular carcinoma (HCC), and accounts for approximately 780,000 deaths every year.

9 Oct 2019

Study confirms effectiveness of a combination therapy for advanced liver cancer

Liver cancer affects hundreds of thousands of people annually, and there are few viable therapies for the advanced stages of its most common form--hepatocellular carcinoma.

6 Sep 2019

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published DATE in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University of Alabama at Birmingham School of Medicine.

From PLOS ONE 13 Aug 2019

Novel biomarker-guided approach has potential for treatment of common liver cancer

A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.

16 Jul 2019

Comprehensive cell atlas of the human liver

The liver is one of the largest and most versatile organs of the human body. It turns sugars, proteins, and fats from our food into substances useful for the body and releases them to the cells.

11 Jul 2019

Study finds link between poor oral health and increased risk of liver cancer

Poor oral health is associated with a 75% increased risk of hepatocellular carcinoma, the most common form of liver cancer, new research published in UEG Journal has found.

20 Jun 2019

Researchers succeed in conquering chronic infection with hepatitis B virus

Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

11 Jun 2019

Receiving blood transfusion during liver cancer surgery has higher risk of recurrence and death

Receiving a blood transfusion during curative surgery for the most common type of liver cancer is associated with a much higher risk of cancer recurrence and dying prematurely, according to new research being presented at this year's Euroanaesthesia congress in Vienna, Austria

3 Jun 2019

New targeted therapy using radio waves blocks growth of liver cancer cells, study shows

A new targeted therapy using non-thermal radio waves has been shown to block the growth of liver cancer cells anywhere in the body without damaging healthy cells, according to a study conducted by scientists at Wake Forest School of Medicine, part of Wake Forest Baptist Health.

31 May 2019

Research reveals immunomodulatory role of ent-kaurane diterpenoids toward NK cells

As early responders in the surveillance of malignant cells, natural killer cells play a significant role in the control of transformed cells at the tumor initiation stage through direct cytolysis. For this reason, NK cell-based immunotherapy is a potential therapeutic strategy for tumor sufferers.

31 May 2019

Hepatocellular Carcinoma News and Research

Further Reading

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Deaths from liver cancer increased 3-fold over 20 years in England

Proton radiation therapy can help treat patients with hepatocellular carcinoma

Studies support use of proton radiation therapy to treat patients with fatal type of liver cancer

MRI contrast agent enables early detection of liver disease

ACG 2019 to review latest scientific advances in diagnosis and treatment of digestive diseases

IDIBELL researchers identify involvement of cell membrane protein in liver cancer

Study shows why fatty liver disease contributes to increase in liver cancer

Spectrum Health, MSU researchers aim to find new or better treatments for "orphan diseases"

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

Scientists demonstrate potential method for treating advanced liver cancers

Study confirms effectiveness of a combination therapy for advanced liver cancer

Human apolipoprotein E promotes hepatitis B virus infection

Novel biomarker-guided approach has potential for treatment of common liver cancer

Comprehensive cell atlas of the human liver

Study finds link between poor oral health and increased risk of liver cancer

Researchers succeed in conquering chronic infection with hepatitis B virus

Receiving blood transfusion during liver cancer surgery has higher risk of recurrence and death

New targeted therapy using radio waves blocks growth of liver cancer cells, study shows

Research reveals immunomodulatory role of ent-kaurane diterpenoids toward NK cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News